ARLIZBETH ARIZANGA LUNA: Open Payments
NPI 1518314616 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 21 payments from 7 companies in 2025. Trend: 2023 $638 · 2024 $418 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $140 |
| Janssen Biotech, Inc. | 3 | $78 |
| TerSera Therapeutics LLC | 2 | $67 |
| ANI Pharmaceuticals, Inc. | 2 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Sandoz Inc. | 1 | $21 |
Products named: TREMFYA, Otezla, Quzyttir, PURIFIED CORTROPHIN GEL, ENBREL, OFEV, JUBBONTI, EVENITY.
Industry payments across CA — which companies pay providers there.
